David Zaccardelli | executive |
Mark Hahn | executive |
Lin Tsai | analyst |
Christopher Martin | executive |
Yasmeen Rahimi | analyst |
Caroline Kimberly Pocher | analyst |
Xinwei An | analyst |
Joon Lee | analyst |
Tara Rheault | executive |
Thomas Shrader | analyst |
Welcome to Verona Pharma's Fourth Quarter and Full Year Quarter 2023 Financial Results and Operating Highlights Conference Call. [Operator Instructions] Earlier this morning, Verona Pharma issued a press release announcing its financial results for the 3 months and full year ended December 31, 2023. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com.
Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans and prospects are forward-looking statements.